argipressin,beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-val(4)- has been researched along with Inappropriate ADH Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baláspiri, L; Csáti, S; László, FA | 1 |
| Baláspiri, L; Csáti, S; László, FA; Manning, M | 1 |
2 other study(ies) available for argipressin,beta-mercapto-beta,beta-cyclopentamethylenepropionic acid(1)-val(4)- and Inappropriate ADH Syndrome
| Article | Year |
|---|---|
Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
Topics: Animals; Arginine Vasopressin; Body Water; Brain; Brain Edema; Diuresis; Hyponatremia; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Rats, Inbred Strains; Urination; Vasopressins | 1984 |
Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat.
Topics: Animals; Arginine Vasopressin; Brain; Brain Edema; Disease Models, Animal; Diuresis; Female; Inappropriate ADH Syndrome; Male; Natriuresis; Osmolar Concentration; Rats; Sodium; Vasopressins | 1984 |